Status:
TERMINATED
Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
Organon
Conditions:
Sperm DNA Impact on ART Outcomes
Eligibility:
MALE
18+ years
Brief Summary
The purpose of this study is to establish a new criteria with which to judge the quality of sperm samples submitted for artificial reproductive treatments. It is believed that this type of testing can...
Eligibility Criteria
Inclusion
- needs interventions through artificial reproductive treatment to achieve a pregnancy
Exclusion
- severly oligozoospermic patients
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00875095
Start Date
October 1 2007
End Date
December 1 2008
Last Update
September 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Center for Human Reproduction
Manhasset, New York, United States, 11030